Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Thomas, Douglas D.

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred

12 Issues per year


IMPACT FACTOR 2016: 3.273

CiteScore 2016: 3.01

SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751

Online
ISSN
1437-4315
See all formats and pricing
In This Section
Volume 382, Issue 11 (Nov 2001)

Issues

Splice Variants of Human Cathepsin L mRNA Show Different Expression Rates

Abulizi Abudula / Winfried Rommerskirch / Ekkehard Weber / Dagmar Günther / Bernd Wiederanders
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2001.193

Abstract

Human cathepsin L (hCATL) mRNA occurs in vivo in at least three splice variants. They differ in the length of exon 1, which comprises 278 nucleotides (hCATLA), 188 nucleotides (hCATLA2) and 132 nucleotides (hCATLA3), respectively. We describe here the shortest variant for the first time. This form is predominant in all tissues and cells examined so far, including malignant tumors. We studied the expression rate of the three mRNA variants in order to explain why malignant kidney tumors show low cathepsin L activity despite of high mRNA levels. The variant hCATLA3 showed the highest expression rate in vitro and in vivo. Based on these results, we suggest a cisacting element on human cathepsin L mRNA which can be bound by a negative transacting regulator, thus leading to reduced expression rates.

About the article

Published Online: 2005-06-01

Published in Print: 2001-11-13



Citation Information: Biological Chemistry, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2001.193. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Klaudia Brix, Joseph McInnes, Alaa Al-Hashimi, Maren Rehders, Tripti Tamhane, and Mads H. Haugen
Protoplasma, 2015, Volume 252, Number 3, Page 755
[2]
Dibyendu Dana, Anibal R. Davalos, Shatarupa De, Pratikkumar Rathod, Ranjith K. Gamage, Juliana Huestis, Nisar Afzal, Yuriy Zavlanov, Suneeta S. Paroly, Susan A. Rotenberg, Gopal Subramaniam, Kevin J. Mark, Emmanuel J. Chang, and Sanjai Kumar
Bioorganic & Medicinal Chemistry, 2013, Volume 21, Number 11, Page 2975
[3]
H. Schmid, R. Sauerbrei, G. Schwarz, E. Weber, H. Kalbacher, and C. Driessen
Biological Chemistry, 2002, Volume 383, Number 7-8
[4]
Jochen Reiser, Brian Adair, and Thomas Reinheckel
Journal of Clinical Investigation, 2010, Volume 120, Number 10, Page 3421

Comments (0)

Please log in or register to comment.
Log in